Previous preclinical studies also showed that [177Lu]Lu-PSMA-I&T and [177Lu]Lu-PSMA-617 have comparable tumor uptake 1 h after injection, with the latter having a slightly higher uptake [31, 34]. Here, FOLH1 is linked to neoplasm.